BTB Therapeutics, Inc.
Company

BTB Therapeutics, Inc.

Biotechnology Research 4 employees
Employees
4
Contacts
2
Emails
2

BTB Therapeutics, Inc. Overview

Industry
Biotechnology Research
Employees
4
Founded
2024
Funding
3.3M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About BTB Therapeutics, Inc.

BTB Therapeutics, Inc. was originally founded in 2020 in Kyoto based on the transcriptomics drug discovery programs of Professor Masatoshi Hagiwara of Kyoto University. We are developing a non-opioid analgesic as a breakthrough modality to solve the opioid crisis. In addition, our pipeline includes RNA-modifying compounds to treat rare genetic diseases and to enhance the efficacy of cancer immunotherapy. We completed US corporate inversion in January 2025 and now BTB Therapeutics, Inc. is located in Escondido, CA with its operating subsidiary in Kyoto, Japan.

BTB Therapeutics, Inc. Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

BTB Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Takashi Kiyoizumi Life Science Industry Executive
Email
Chiaki Murata Btb Therapeutics, Inc.
View
Dave Snyder Vice Chairman and Lead Independent
Email
Masatoshi Hagiwara Kyoto University (京都大学) - 大学教授
View

Employees by Management Level

Individual contributor 3 profiles
Senior / Lead 1 profile

Compare Similar Companies to BTB Therapeutics, Inc.